Dow Jones
37.775,38 +22,07 (+0,06%) Nasdaq
15.601,50 -81,87 (-0,52%) Nikkei 225
37.127,10 -952,60 (-2,50%) EUR/USD
1,0639 -0,0007 (-0,06%) Bitcoin EUR
58.609,43 +331,56 (+0,57%) CMC Crypto 200
1.286,64 +401,10 (+44,06%)
Globus Medical, Inc. (GMED)
Dopo ore:
| Chiusura precedente | 51,20 |
| Aperto | 51,17 |
| Denaro | 0,00 x 800 |
| Lettera | 0,00 x 1200 |
| Min-Max giorno | 50,65 - 51,54 |
| Intervallo di 52 settimane | 43,39 - 62,88 |
| Volume | |
| Media Volume | 1.059.556 |
| Capitalizzazione | 6,87B |
| Beta (5 anni mensile) | 1,10 |
| Rapporto PE (ttm) | 47,43 |
| EPS (ttm) | 1,07 |
| Prossima data utili | 02 mag 2024 - 06 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 61,46 |
GlobeNewswireTwenty Years of the NuVasive XLIF Procedure Celebrated at the Society for Minimally Invasive Spine Surgery 2023 Annual Forum
AUDUBON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, celebrated twenty years of the NuVasive XLIF procedure at the Society for Minimally Invasive Spine Surgery (SMISS) ’23 Annual Forum. “Very few medical technology innovations have transformed an industry like the NuVasive XLIF procedure. Twenty years of XLIF has produced two decades of unmatched clinical validation, represented by an incredible body of evidence on the re
GlobeNewswireGlobus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023
AUDUBON, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it will continue its partnership with EUROSPINE as a silver sponsor and will attend EUROSPINE 2023 held October 4 to 6 in Frankfurt. “As leaders in the musculoskeletal device industry, we are committed to procedurally integrated innovation that enables surgeons to deliver more intelligent surgery,” said Dan Scavilla, chief executive officer at Globus Me
- GlobeNewswire
NuVasive Specialized Orthopedics Launches Precice Bone Transport in International Markets
AUDUBON, Pa., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of NuVasive Specialized Orthopedics’ (NSO) Precice Bone Transport system in targeted regions. The latest addition to the less invasive NSO portfolio is now CE-marked and approved and available in select markets. “The NSO difference is our deep commitment to making complex reconstruction simple and more reproducible,” said Pete Ligo
